MCGAW PARK, Ill. -- During its recent annual national sales training meeting in Orlando, Cardinal Health honored 29 leading manufacturers with awards for extraordinary industry performance. Winners represent organizations that provide products and services for the hospital supply, laboratory and ambulatory care distribution businesses of Cardinal Health.
 "It is important to acknowledge the significant efforts and achievements that these laboratory and medical-surgical suppliers have made in working with us to deliver valuable solutions to healthcare providers," said Sandy Rigopoulos, Cardinal Health's vice president of vendor management and administration, Supply Chain Services - Medical.
Cardinal Health uses numerous criteria to evaluate its suppliers including industry leadership, sales and marketing excellence, superior customer service, financial and operational standards and innovation in product solutions.
 "We are focused on providing superior products and services to all of our customers. These awards recognize suppliers who share that focus," said Eric Timm, Cardinal Health's vice president of marketing, Hospital Supply Distribution.
 This year's award winners include:
3M Healthcare
Andover Coated Products
Bard Medical Division
Becton-Dickinson
Colgate-Palmolive
Current Technologies
Dale Medical Products
DiaSorin
DJ Orthopedics
Ethicon Endo-Surgery
Gillette Company
Huntleigh Healthcare
International Med Surg Connection
J&J ASP
Mabis Healthcare
Medex
Medi-Flex
Midmark
Miltex
Nerl Diagnostics
Ortho-Clinical Diagnostics
Paperpak
Quidel
Regent Medical
Sage Products
Sakura Finetek
Tyco Healthcare - Kendall
Wampole
Welch Allyn
 Source: Cardinal Health, Inc.
Â
Â
Â
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.